Consultation for safe use of dietary and herbal supplements in hematology patients
Naturopathic-pharmacological Consultation on the Use of Dietary Supplements in Patients With Hematological Diseases
This study is testing whether talking to experts about dietary and herbal supplements can help people with blood disorders use them safely and effectively.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Bnai Zion Medical Center Government |
| Locations | 1 site (Haifa) |
| Trial ID | NCT05982262 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the impact of naturopathic-pharmacological consultations on patients with hematologic diseases. Participants will complete questionnaires before and after consultations to assess their knowledge and safety regarding dietary and herbal supplements. Some patients may receive recommendations for supplements that could alleviate their symptoms without interfering with their current medications. The study seeks to enhance the understanding and safe use of these supplements among patients.
Who should consider this trial
Good fit: Ideal candidates are patients with hematologic diseases who are interested in learning about or currently using dietary and herbal supplements.
Not a fit: Patients who do not have a hematologic condition or are not interested in dietary and herbal supplements may not benefit from this study.
Why it matters
Potential benefit: If successful, this could lead to safer and more effective use of dietary and herbal supplements for patients with hematologic conditions.
How similar studies have performed: While there is limited data on this specific approach, similar studies have shown potential benefits in improving patient safety and knowledge regarding supplement use.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Followed up for a hematological condition 2. Ability to fill simple questionnaires in Hebrew, Russian or Arabic 3. Indication for consultation: 1. Patient's request to expand knowledge about the use of DHS 2. Patient using DHS 3. Patient's desire to start using DHS 4. Patient that is interested in hearing about the use of DHS for his/her health condition 5. Medical or nursing team's recommendation to take DHS for medical treatment or to improve compliance with conventional treatment. Exclusion Criteria: None
Where this trial is running
Haifa
- Bnai Zion Medical Center — Haifa, Israel (Recruiting)
Study contacts
- Principal investigator: Ilana Levy Yurkovski, MD — Bnai Zion Medical Center
- Study coordinator: Dana Weizer
- Email: dana.weizer@b-zion.org.il
- Phone: 972543295952
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.